4
Changes in Ownership
TriSalus Life Sciences, Inc. Filed Acc 0001628280-26-065326
Chief of Research sold 296 shares at $4.39 ($1,299)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cox Bryan F. Chief of Research | 2026-10-05 | Sale | −296 | $4.39 | $1,299 | 162,805 | D |
| Open-market sales · 296 sh · avg $4.39 · $1,299 | |||||||
Loading xslF345X06/wk-form4_1791403369.xml…